|
|
Breast Cancer
Latest Research
New research shows women with early-stage breast cancer who took
the drug letrozole, an aromatase inhibitor, after they completed
five years of tamoxifen therapy significantly reduced their risk of
breast cancer recurrence.
|
| |
|
|
|
